IDEAYA Biosciences, Inc., a precision medicine oncology company, has announced the issuance of non-qualified stock options to nine newly hired employees, under its 2023 Employment Inducement Incentive Award Plan. The stock options, totaling 664,600 shares, are granted as an inducement for employment under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $20.05 per share, matching the closing price of IDEAYA's common stock on the grant date, and come with a 10-year term. Vesting occurs over four years, with 25% vesting on the first anniversary and the remainder vesting monthly over the next three years, contingent upon continued employment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.